000 | 07930cam a22007938i 4500 | ||
---|---|---|---|
001 | on1042077388 | ||
003 | OCoLC | ||
005 | 20201009115341.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 180619s2018 nju ob 001 0 eng | ||
010 | _a 2018029534 | ||
040 |
_aDLC _beng _erda _cDLC _dOCLCO _dOCLCF _dN$T _dEBLCP _dUIU _dDG1 _dMERER _dUKMGB _dOTZ _dOCLCQ |
||
066 | _c(S | ||
015 |
_aGBB8I6276 _2bnb |
||
016 | 7 |
_a019080867 _2Uk |
|
019 | _a1054128975 | ||
020 |
_a9781119312307 _q(ePub) |
||
020 |
_a1119312302 _q(ePub) |
||
020 |
_a9781119312321 _q(electronic bk. : oBook) |
||
020 |
_a1119312329 _q(electronic bk. : oBook) |
||
020 |
_z9781119312284 _q(hardback) |
||
020 |
_z1119312280 _q(hardback) |
||
020 |
_a9781119312291 _q(electronic bk.) |
||
020 |
_a1119312299 _q(electronic bk.) |
||
029 | 1 |
_aUKMGB _b019080867 |
|
029 | 1 |
_aCHVBK _b549244638 |
|
029 | 1 |
_aCHNEW _b001025653 |
|
035 |
_a(OCoLC)1042077388 _z(OCoLC)1054128975 |
||
037 |
_a9781119312307 _bWiley |
||
042 | _apcc | ||
050 | 1 | 0 | _aRA1238 |
072 | 7 |
_aMED _x071000 _2bisacsh |
|
082 | 0 | 0 |
_a615.9/02 _223 |
084 |
_aSCI013040 _aTEC010010 _2bisacsh |
||
049 | _aMAIN | ||
100 | 1 |
_aJjemba, Patrick K., _eauthor. |
|
245 | 1 | 0 |
_aPharma-ecology : _bthe occurrence and fate of pharmaceuticals and personal care products in the environment / _cPatrick K. Jjemba. |
250 | _aSecond edition. | ||
263 | _a1811 | ||
264 | 1 |
_aHoboken, NJ : _bWiley, _c[2018] |
|
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
520 |
_a"This book links the health and environmental sciences professions; concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment. Knowledge about the ecological impact of PPCPs is dynamically changing as better and more sensitive detection techniques become available, and new information has come up since the book first published. This new edition brings the readership up-to-date and continues to bridge the gap between medicine / public health and environmental science. It is an approach that arouses interest in the topic among health-care providers, engineers, toxicologists, pharmacists, ecologists, microbiologists, chemists, and policy makers. Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice Updates information on PPCPs ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter"-- _cProvided by publisher. |
||
520 |
_a"Sales handles: - Links the health and environmental sciences professions' concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment - Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed - Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice - Updates information on PPCPs' ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter Bridges the gap between medicine / public health and environmental science Market description: Engineers, toxicologists, ecologists, microbiologists, chemists involved in pollution and environmental analysis. Regulatory agencies like the EPA or FDA, which are concerned with the potential negative impacts of pharmaceutical products and waste. Pharmaceutical professionals who design and develop pharmaceutical and personal care products (PPCPs) and who need to understand how they impact the environment"-- _cProvided by publisher. |
||
504 | _aIncludes bibliographical references and index. | ||
588 | 0 | _aPrint version record and CIP data provided by publisher; resource not viewed. | |
505 | 0 | _aIntro; Title Page; Copyright Page; Contents; Preface; Chapter 1 Usage of Pharmaceutical and Personal Care Products; 1.1 Pharmaceutical Consumption Trends; Study Questions; References; Chapter 2 Most Prescribed Pharmaceuticals and Related Endpoints; 2.1 Antihypertensive and Cardiovascular; 2.2 Anxiolytic Sedatives, Hypnotics, and Antipsychotics; 2.3 Analgesics and Anti-inflammatory Drugs; Study Questions; References; Chapter 3 Usage of Antimicrobial Agents and Related Endpoints; 3.1 Cell Wall Synthesis Inhibiting Antibiotics; 3.2 Inhibitors of Protein Synthesis | |
505 | 8 | _a3.3 Nucleic Acid Synthesis Inhibitors3.4 Antagonism to Metabolic Processes; 3.5 Antibiotics that Disrupt Membrane Integrity; 3.6 Other Antimicrobials; Study Questions; References; Chapter 4 Usage of Other Groups of Pharmaceuticals and Related Endpoints; 4.1 Gastrointestinal Drugs; 4.2 Antidiabetic Drugs; 4.3 Diuretics and Electrolytes; 4.4 Thyroid System Medication; 4.5 Respiratory Drugs; 4.6 Oral Contraceptive and Reproductive Therapeutics; 4.7 Biophosphonates and Other Skeletal Ailment Drugs; 4.8 Steroids; 4.9 Hematologic Drugs; 4.10 Nutritional Drugs; 4.11 Triptans; 4.12 Anesthetics | |
505 | 8 | _a4.13 Antineoplastics and ImmunosuppressantsStudy Questions; References; Chapter 5 Personal Care Products of Environmental Concern; 5.1 Fragrances and Musks; 5.2 Ultraviolet Light Filters; 5.3 Detergents; 5.4 Disinfectants; Study Questions; References; Chapter 6 Detection and Occurrence of PPCPs in the Environment; 6.1 Detection of PPCPs in the Environment; 6.1.1 Detection Using Instrumentation; 6.1.2 Detection Using Bioassays; 6.2 Occurrence of PPCPs in Various Environments; 6.2.1 Aquatic Systems; 6.2.1.1 PPCPs in Wastewater; 6.2.1.2 PPCPs in Surface Water; 6.2.1.3 PPCPs in Groundwater | |
505 | 8 | _a6.2.1.4 PPCPs in Potable Water6.2.2 Occurrence of PPCPs in Sediments; 6.2.3 Occurrence of PPCPs in Soil; 6.2.4 PPCPs in Aerial Environments; 6.3 Excretion as a Driver of Pharmaceutical Occurrence in the Environment; Study Questions; References; Chapter 7 Ecopharmacokinetics and Ecopharmacodynamics of PPCPs; 7.1 Overview of Pharmacokinetics and Pharmacodynamics; 7.1.1 PPCP Sorption and Bioavailability in the Environment; 7.1.2 Compound Half-life and Clearance; 7.2 Degradation of PPCPs in the Environment; 7.2.1 Degradation of Antibiotics in the Environment | |
650 | 0 |
_aDrugs _xToxicology. |
|
650 | 0 |
_aHygiene products _xToxicology. |
|
650 | 0 |
_aDrugs _xEnvironmental aspects. |
|
650 | 0 |
_aHygiene products _xEnvironmental aspects. |
|
650 | 0 | _aEnvironmental toxicology. | |
650 | 7 |
_aSCIENCE / Chemistry / Organic. _2bisacsh |
|
650 | 7 |
_aTECHNOLOGY & ENGINEERING / Environmental / Pollution Control. _2bisacsh |
|
650 | 7 |
_aDrugs _xToxicology. _2fast _0(OCoLC)fst00898958 |
|
650 | 7 |
_aEnvironmental toxicology. _2fast _0(OCoLC)fst00913536 |
|
650 | 7 |
_aMEDICAL / Pharmacology _2bisacsh |
|
655 | 4 | _aElectronic books. | |
776 | 0 | 8 |
_iPrint version: _aJjemba, Patrick K., author. _tPharma-ecology _bSecond edition. _dHoboken, NJ : Wiley, [2018] _z9781119312284 _w(DLC) 2018027837 |
856 | 4 | 0 |
_uhttps://doi.org/10.1002/9781119312321 _zWiley Online Library |
880 | 8 |
_6505-00/(S _a7.2.1.1 Degradation of Quinolone Compounds7.2.1.2 Fate of β-Lactams and Cephalosporins; 7.2.1.3 Degradation of Tetracyclines; 7.2.1.4 Degradation of Macrolides; 7.2.1.5 Fate of Other Important Groups of Antibiotics; 7.2.2 Degradation of Analgesics and Anti-inflammatory Drugs; 7.2.3 Degradation of Estrogens and Other Reproductive Hormones; 7.2.4 Degradation of Other Important Pharmaceuticals; 7.2.5 Degradation of Surfactants; 7.3 Role of Physicochemical Factors in the Fate of PPCPs in the Environment; 7.3.1 Molecular Size as an Attribute to Absorption and Persistence |
|
994 |
_a92 _bDG1 |
||
999 |
_c79110 _d79110 |